Category: Drug Development
Oceania Drug Development
-
Artificial Intelligence in Healthcare Market Assessment, By Component [Hardware, Software and Services], By Technology [Machine Learning (ML), Natural Language Processing (NLP), Context-Aware Computing, Robotic Process Automation (RPA), Computer Vision and Others], By Application [Robot-Assisted Surgery, Administrative Workflow Assistance, Cybersecurity, Virtual Nursing Assistant, Clinical Trials, Diagnosis, Customer Service Chatbots, Drug Discovery and Others], By End-user [Hospitals & Clinics, Pharmaceutical & Biotechnology, Patients and Others], By Region [North America, Europe, Asia Pacific, Middle East & Africa and South America]
... Administrative Workflow Assistance, Cybersecurity, Virtual Nursing Assistant, Clinical Trials, Diagnosis, Customer Service Chatbots, Drug Discovery and Others], By End-user [Hospitals & Clinics, Pharmaceutical & Biotechnology, Patients and Others], By Region [North America, Europe, Asia Pacific, ... Read More
-
HER-2 Negative Breast Cancer Market, By Type of Treatment (Chemotherapy, Radiation, Hormonal Therapy, and Other Types of Treatments) and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Outlook, and Opportunity Analysis, 2023 - 2030 HER2-negative negative breast cancer means that the cancerous cells do not contain high levels of the protein HER2. Cancer cells that are HER2 negative may grow more slowly ... Read More
-
Lab-on-a-chip and Microarrays (Biochip) Market, By Type (Lab-on-a-chip and Microarray), By Product (Instruments, Reagents and Consumables, and Software and Services), By Application (Clinical Diagnostics, Drug Discovery, Genomics and Proteomics, and Other Application), By End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, and Academic and Research Institutes), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, and Academic and Research Institutes), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - ... Read More
-
Australia & New Zealand Healthcare CROs Market Size, Share & Trends Analysis Report By Phase Type (Drug Discovery, Preclinical, Clinical), By Service, By Application, By End-use, By Country, And Segment Forecasts, 2023 - 2030
... & New Zealand Healthcare CROs Market Growth & Trends The Australia & New Zealand healthcare CROs market size is expected to reach USD 2.4 billion by 2030, according to a new report by Grand View ... Read More
-
m-RNA Synthesis Service Market, By Application (Therapeutic Development, Vaccine Production, Drug Discovery, Others), By Scale of Operation (Research, Commercial), By End User (Biopharmaceutical Companies, Contract research organizations (CROs), Others), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Messenger RNA (mRNA) synthesis, using DNA as the template, is called transcription. The mRNA carries the genetic information ... Read More
-
Bovine Plasma Market, by Grade (Technical and Standard), by Origin (U.S., Australia, New Zealand, and Others (Brazil, Mexico, etc.)), by Application (Cell Culture Media, Vaccine Production, Drug Discovery, and Others (Forensic Studies, in vitro diagnostics, etc.)), by End User (Biopharmaceutical Industry, Academic & Research Institutes, and Others (Diagnostic Laboratories, Forensic Laboratories, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... etc.)), by End User (Biopharmaceutical Industry, Academic & Research Institutes, and Others (Diagnostic Laboratories, Forensic Laboratories, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and ... Read More
-
Asia-Pacific Laboratory Animal Diets Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Diet Type (Standard Diets, Irradiated Diets, and Autoclavable Diets), Animal (Mouse, Cat, Dog, Rabbit, Chicken, and Others), Application (Drug Discovery & Personalized Medicine, Regenerative Medicine, Pathology of Infectious Diseases, Drug Toxicity & Efficacy Testing, and Others), and End User (Pharmaceutical & Biopharmaceutical Companies, Research & Academic Institutes, and Others)
... & Personalized Medicine, Regenerative Medicine, Pathology of Infectious Diseases, Drug Toxicity & Efficacy Testing, and Others), and End User (Pharmaceutical & Biopharmaceutical Companies, Research & Academic Institutes, and Others) The laboratory animal diets market in ... Read More
-
Asia Pacific Digital Pathology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Scanners, Software, Storage, and Communication Systems), Application (Telepathology, Disease Diagnosis, Drug Discovery, and Training & Education), and End User (Educational, Clinical, and Pharma & Biotech Companies)
... (Educational, Clinical, and Pharma & Biotech Companies) The digital pathology market in Asia Pacific is expected to grow from US$ 206.30 million in 2022 to US$ 426.03 million by 2028. It is estimated to grow ... Read More
-
Global Metabolomics Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product and Services (Metabolomics Instrument, Metabolomics bioinformatics tools and services), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Metabolic Disorders), Application (Biomarker Discovery, Toxicology, Nutrigenomics, Personalized Medicine, Drug Discovery, Functional Genomics) and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
... Discovery, Toxicology, Nutrigenomics, Personalized Medicine, Drug Discovery, Functional Genomics) and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) Market Overview: The scientific study of chemical processes, including metabolites, is known as ... Read More
-
Global Biomarkers Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Type (Molecular, Radiographic, Histologic, Physiologic), Application (Disease Susceptibility/Risk, Diagnostic, Drug Discovery & Development, Personalized Medicine, and Others), Disease (Oncology, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders) and Regions (North America, Asia Pacific, Europe, Latin America Middle East and Africa)
... Disorders) and Regions (North America, Asia Pacific, Europe, Latin America Middle East and Africa) Market Overview: Biomarkers are biological measures used to conduct a diagnostic evaluation, such as blood pressure or cholesterol level, as well ... Read More
-
Cell Culture Market, by Product Type (Instruments and Consumables), by Application (Vaccine Production, Gene Therapy, Cancer Research, Tissue Culture, Drug Development, and Others), by End User (Academic & Research Institutions, and Pharmaceutical and Biotechnology Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The technique of growing cells outside the human body itself is a ... Read More
-
Live Cell Imaging Market, By Product (Equipment, Consumables, and Software and Services), By Application (Cell Biology, Developmental Biology, Stem Cell Biology, Drug Discovery, and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Live cell imaging is the study of living cells using time-lapse microscopy. This technique has revolutionized cell biology by facilitating ... Read More
-
Contract Pharmaceutical Manufacturing Market, by Service Type (Contract Manufacturing Organization (CMO) (API Manufacturing, Final Dosage Form Manufacturing, and Packaging), Contract Research Organization (CRO) (Drug Discovery, Preclinical Studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management and Protocol Development)), by Molecule Type (Small Molecules and Large Molecules), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... III, Phase IIIb – IV, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management and Protocol Development)), by Molecule Type (Small Molecules and Large Molecules), and by Region (North America, Latin America, Europe, ... Read More
-
Recombinant DNA Technology Market, by Product Type (Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy and Gene Editing), by Application (Therapeutics, Agriculture, and Research), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Recombinant DNA (rDNA) technology is a novel technique that has led to advances in a number of ... Read More
-
Next Generation Sequencing Market, by Technology (Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Targeted Re-sequencing, and Others), by Application (Drug Discovery, Personalized Medicine and Genetic Screening, Disease Diagnosis, Agriculture and Animal Research, and Others), by End User (Hospital, Research Centers, Pharma and Biotech Firms, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by End User (Hospital, Research Centers, Pharma and Biotech Firms, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
Coronavirus Vaccine Market, by Vaccine Type (Inactivated Virus, Protein Subunit, Non-replicating Viral Vector, Repurposed Vaccines, RNA Vaccine, and DNA Vaccine) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -
... Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 The coronavirus (COVID-19) pandemic is the most recent outbreak, which was first reported on December 31, 2019, in Wuhan, China. COVID-19 is a viral infection caused ... Read More
-
Precision Medicine Market, By Technology (Bioinformatics, Gene Sequencing, Drug Discovery, Precision Molecular Diagnostics, and Big Data Analytics), By Application (Oncology (Breast cancers, Lung Cancer and Others), Central Nervous System, Hematology, Respiratory, Immunology, and Others)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2019 - 2027
... By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2019 - 2027 Precision medicine guides disease diagnosis, treatment, and prevention of cancer, hereditary diseases, ... Read More
-
Asia Pacific Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Asia Pacific pharmacogenomics market is expected to reach US$ 2,679.64 million by 2028 from US$ 1,148.36 million in 2021. ... Read More
-
Asia-pacific Drug Discovery Market Forecast 2022-2030
... offer lucrative research and clinical trials opportunities for pharmaceuticals and CROs. MARKET INSIGHTS Taiwan, Japan, Australia & New Zealand, India, Singapore, Indonesia, South Korea, China, and Rest of Asia-Pacific are analyzed for the Asia-Pacific drug ... Read More
-
Asia Pacific Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market in Asia Pacific is expected to grow from US$ 1,051.58 million in 2021 to US$ 3,557.63 million by ... Read More
-
Blood Based Biomarker Market, By Type (Screening Biomarker, Diagnosis Biomarker, and Others), By Disease (Cancer, Neurological Disorders, and Others), By Application (Diagnostics, Drug Discovery, and Personalized Medicine), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The term biomarker, or biological marker, refers to a broad range of measures that capture what is happening in a ... Read More
-
Antiviral Drugs Market, by Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors and Others), by Type (Branded and Generics), by Application (HIV, Hepatitis, Herpes, Influenza, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Antiviral drugs are prescription ... Read More
Research Assistance
